The Washington State Hub and Spoke Model to increase access to medication treatment for opioid use disorders

被引:34
|
作者
Reif, Sharon [1 ]
Brolin, Mary F. [1 ]
Stewart, Maureen T. [1 ]
Fuchs, Thomas J. [3 ]
Speaker, Elizabeth [2 ]
Mazel, Shayna B. [1 ]
机构
[1] Brandeis Univ, Heller Sch Social Policy & Management, Inst Behav Hlth, 415 South St, Waltham, MA 02453 USA
[2] Washington State Dept Social & Hlth Serv, Res & Data Anal, 1115 Washington St,POB 4520, Olympia, WA 98504 USA
[3] Washington State Hlth Care Author, Div Behav Hlth & Recovery, 626 8th Ave SE,POB 45330, Olympia, WA 98504 USA
基金
美国国家卫生研究院;
关键词
SUBSTANCE USE DISORDERS; ASSISTED TREATMENT; BUPRENORPHINE-NALOXONE; COLLABORATIVE CARE; TREATMENT PROGRAMS; VERMONT HUB; IMPLEMENTATION; BARRIERS; PHYSICIANS; PHARMACOTHERAPY;
D O I
10.1016/j.jsat.2019.07.007
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Introduction: The federal Opioid State Targeted Response (Opioid STR) grants provided funding to each state to ramp up the range of responses to reverse the ongoing opioid crisis in the U.S. Washington State used these funds to develop and implement an integrated care model to expand access to medication treatment and reduce unmet need for people with opioid use disorders (OUD), regardless of how they enter the treatment system. This paper examines the design, early implementation and results of the Washington State Hub and Spoke Model. Methods: Descriptive data were gathered from key informants, document review, and aggregate data reported by hubs and spokes to Washington State's Opioid STR team. Results: The Washington State Hub and Spoke Model reflects a flexible approach that incorporates primary care and substance use treatment programs, as well as outreach, referral and social service organizations, and a nurse care manager. Hubs could be any type of program that had the required expertise and capacity to lead their network in medication treatment for OUD, including all three FDA-approved medications. Six hub-spoke networks were funded, with 8 unique agencies on average, and multiple sites. About 150 prescribers are in these networks (25 on average). In the first 18 months, nearly 5000 people were inducted onto OUD medication treatment: 73% on buprenorphine, 19% on methadone, and 9% on naltrexone. Conclusions: The Washington State Hub and Spoke Model built on prior approaches to improve the delivery system for OUD medication treatment and support services, by increasing integration of care, ensuring "no wrong door," engaging with community agencies, and supporting providers who are offering medication treatment. It used essential elements from existing integrated care OUD treatment models, but allowed for organic restructuring to meet the population needs within a community. To date, there have been challenges and successes, but with this approach, Washington State has provided medication treatment for OUD to nearly 5000 people. Sustainability efforts are underway. In the face of the ongoing opioid crisis, it remains essential to develop, implement and evaluate novel models, such as Washington's Hub and Spoke approach, to improve treatment access and increase capacity.
引用
收藏
页码:33 / 39
页数:7
相关论文
共 50 条
  • [31] Advancing the implementation and sustainment of medication assisted treatment for opioid use disorders in prisons and jails
    Warren J. Ferguson
    Joan Johnston
    Jennifer G. Clarke
    Peter J. Koutoujian
    Kathleen Maurer
    Colleen Gallagher
    Julie White
    Dyana Nickl
    Faye S. Taxman
    Health & Justice, 7
  • [32] Medication-assisted treatment for opioid use disorders in correctional settings: An ethics review
    Ludwig, Ariel S.
    Peters, Roger H.
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2014, 25 (06) : 1041 - 1046
  • [33] The Community-Based Medication-First program for opioid use disorder: a hybrid implementation study protocol of a rapid access to buprenorphine program in Washington State
    Banta-Green, Caleb J.
    Owens, Mandy D.
    Williams, Jason R.
    Sears, Jeanne M.
    Floyd, Anthony S.
    Williams-Gilbert, Wendy
    Kingston, Susan
    ADDICTION SCIENCE & CLINICAL PRACTICE, 2022, 17 (01)
  • [34] The Community-Based Medication-First program for opioid use disorder: a hybrid implementation study protocol of a rapid access to buprenorphine program in Washington State
    Caleb J. Banta-Green
    Mandy D. Owens
    Jason R. Williams
    Jeanne M. Sears
    Anthony S. Floyd
    Wendy Williams-Gilbert
    Susan Kingston
    Addiction Science & Clinical Practice, 17
  • [35] Evaluation of Swaziland's Hub-and-Spoke Model for Decentralizing Access to Antiretroviral Therapy Services
    Auld, Andrew F.
    Kamiru, Harrison
    Azih, Charles
    Baughman, Andrew L.
    Nuwagaba-Biribonwoha, Harriet
    Ehrenkranz, Peter
    Agolory, Simon
    Sahabo, Ruben
    Ellerbrock, Tedd V.
    Okello, Velephi
    Bicego, George
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2015, 69 (01) : E1 - E12
  • [36] Critical access medication for opioid use disorder (MOUD) treatment facilities in the continental United States
    Pollack, Harold A.
    Lee, Francis
    Paykin, Susan
    Aguilera, Javier Andres Rojas
    DRUG AND ALCOHOL DEPENDENCE REPORTS, 2023, 6
  • [37] Structural and organizational factors shaping access to medication treatment for opioid use disorder in community supervision
    Kennedy-Hendricks, Alene
    Bandara, Sachini
    Merritt, Sydney
    Barry, Colleen L.
    Saloner, Brendan
    DRUG AND ALCOHOL DEPENDENCE, 2021, 226
  • [38] Maternal-Fetal Telemedicine: the impact of a national hub and spoke model on critical access communities
    Haeri, Sina
    Mauricio, Maria
    Lindsley, William
    La Rosa, Mauricio
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2022, 226 (01) : S549 - S549
  • [39] State Policies Could Impede New Efforts to Increase Access to Medications for Opioid Use Disorder
    Barsky, Benjamin A.
    Mehrotra, Ateev
    Huskamp, Haiden A.
    JAMA HEALTH FORUM, 2023, 4 (03):
  • [40] A Hub and Spoke Model for Improving Access and Standardizing Ethics Consultations Across a Large Healthcare System
    Tolchin, Benjamin
    Bruce, Lori
    Mercurio, Mark
    Latham, Stephen R.
    AMERICAN JOURNAL OF BIOETHICS, 2022, 22 (04): : 42 - 45